Sarepta Therapeutics, Inc. 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 4, 2014
Insider Transaction Report
Form 4
Christopher Nishan Garabedian
Director
Transactions
- Award
Incentive Stock Option (right to buy)
2014-02-28+3,444→ 3,444 totalExercise: $29.03Exp: 2024-02-28→ Common Stock (3,444 underlying) - Award
Non-Qualified Stock Option (right to buy)
2014-02-28+186,556→ 186,556 totalExercise: $29.03Exp: 2024-02-28→ Common Stock (186,556 underlying)
Holdings
- 28,078
Common Stock
Footnotes (3)
- [F1]Includes 800 shares acquired under the Sarepta Therapeutics, Inc. 2013 Employee Stock Purchase Plan on February 28, 2014.
- [F2]Reflects a transfer exempt under Rule 16a-12 since the date of the Reporting Persons last ownership report.
- [F3]This option is exercisable at the rate of 25% of the shares on the first anniversary of the date of grant and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on the fourth anniversary of the date of grant.